Why BGPT?
logo

The Evidence Layer for Scientific AI

Ask questions across claims linked to experiments, exact results, limitations, and sources.Know what falsifiable science actually supports before you trust the answer.

Press Enter ↡ to search evidence


     Long Explanation



    Identity and Metrics: A Critical Ambiguity

    The author metrics supplied for "David Byrne" (h-index 1, 3 papers, 6 citations, no listed affiliation) do not correspond to the dominant "David Byrne" profile in OpenAlex (h-index 42, 325 works, 10,223 citations), nor to several other indexed researchers of the same name (h-indices 13–32) . This mismatch means any citation-based verdict on a single individual would be confounded by identity blending β€” a known failure mode of author-level bibliometrics .

    What the Supplied Evidence Actually Contains

    The three indexed papers (a depression-trial factor-analysis protocol, a prostate cancer MRI-hypoxia pilot, and a breast cancer microRNA comparison) have no claim-level evidence records in the supplied research. None of the 19 detailed paper records (koala sperm proteomics, epithelial monolayer mechanics, C9orf72 models, thymic stroma, TBI, lung adenocarcinoma hypoxia, FLEX fusion tags, benzodiazepine binding, DCM risk stratification, Mercury graben, maternal diet microbiome, peach phenotyping) can be reliably attributed to this David Byrne β€” several involve distinct authors such as David Anthony Skerrett-Byrne. Attributing them would commit a name-matching fallacy.

    Conclusion: The available data are insufficient to scientifically evaluate this author's work. What can be stated: an early-career or modestly cited profile (h=1, 3 papers) spanning clinical trial methodology, oncology imaging/genomics, and cancer genomics suggests breadth over depth, but zero supplied full-text evidence precludes rigorous scoring of rigor or novelty. What would change this conclusion: full texts or verified OpenAlex/PubMed linkage of the three listed papers to their actual content and co-author networks.



    Feedback:    

    Updated: November 19, 2026

     BGPT Author Review



    Scientific Quality

    30%

    The supplied profile (h-index 1, 3 papers, 6 citations) indicates minimal citation footprint and no verifiable independent scientific contribution traceable in the provided evidence. The listed papers span applied secondary/pilot analyses rather than primary methodological advances. However, identity ambiguity with multiple same-name researchers (h-index up to 42) makes even this estimate unreliable; the score reflects only what is verifiable.



    Communication Quality

    40%

    Paper titles are clear and conventional (protocol, pilot study, response to reviews), suggesting competent standard scientific communication, but there is no supplied full text, abstract quality, or presentation evidence to judge clarity, engagement, or teaching ability.



    Author Novelty

    30%

    The indexed titles indicate secondary analysis of existing trial data, a small pilot study, and a review response β€” incremental work types with limited original hypothesis generation. No supplied record demonstrates a novel concept, though absence of full texts means novelty cannot be excluded.



    Scientific Rigor

    30%

    No full-text evidence records exist for any of the three attributed papers, so rigor cannot be positively assessed. The profile's reliance on protocol papers and pilot studies with small samples (typical of early-career contributors) suggests limited demonstrated rigor, and no metrics indicate methodological leadership.

     Top Data Sources ExportMCP



     Hypothesis Graveyard



    Assuming the supplied papers belong to the high-citation OpenAlex 'David Byrne' (h=42): refuted by complete mismatch in paper titles, counts, and domains.

     Science Art


    Author Review: David Byrne Science Art

     Science Movie



    Make a narrated HD Science movie for this answer ($64 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT